Physiologically Based Pharmacokinetic Modeling of Metabolic Interactions between n-Hexane and Toluene in Humans
نویسندگان
چکیده
Physiologically based Pharmacokinetic Modeling of Metabolic Interactions Between nHexane and Toluene in Humans: Xiaozhong YU, et al. Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine—Some animal experiments have shown that mutual metabolic inhibition takes place between nhexane and toluene, but we have found only one report dealing with their metabolic interaction at occupationally relevant exposure levels (Bælum et al. 1998). In order to evaluate the effect of dose-dependent metabolic interaction between toluene and n-hexane, especially in occupationally relevant exposure conditions such as relevant exposure levels, physical activities and exposure pat terns, a physio logical ly based pharmacokinetic (PBPK) model for co-exposure to nhexane and toluene was developed. The PBPK model for the binary co-exposure was established by initially validating or refining the existing PBPK models for nhexane and toluene and then linking the individual solvent models via the hepatic metabolism terms. In reporting previous findings, noncompetitive inhibition was assumed and the inhibition constant of toluene on n-hexane biotransformation and that of n-hexane on toluene biotransformation used in simulation were 7.5, 30 μm, respectively, in previous data. According to the model, 8 h of constant exposure to 50 ppm nhexane and 25, 50, 100 and 500 ppm toluene will cause about 7%, 18%, 62% and 96% decreases in the urinary excretion of 2,5-hexanedione (2,5-HD) and 4%, 10%, 25% and 30% increases in the n-hexane concentration in blood at the end of the fifth day of exposure simulated in a standard man at a 25 W work load. Simulations of co-exposure to 50 ppm n-hexane and 50 ppm toluene Received June 26, 1998; Accepted Aug 30, 1998 Correspondence to: X. Yu, Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan in a standard man who inhaled 50 ppm n-hexane with 0 or 50 ppm toluene for 8 h at different work loads suggest that toluene causes a slight decrease in urinary 2,5-HD in the resting condition, a 17% decrease at 25 W, and a 41% decrease at 50 W work load. The simulations of co-exposure in different exposure patterns with the same time-weighted concentration (TWA) of 50 ppm, i.e. 50 ppm for 8 h, 100 ppm of 4 times for 1 h and 200 ppm of twice for 1 h, showed reductions in urinary 2,5-HD of 17%, 40% and 67%, respectively. These simulations suggest that coexposure to n-hexane and toluene around 50 ppm (TWA) could affect urinary n-hexane metabolites to various degrees depending on the fluctuations in exposure concentrations and variety of work activities in the workplace. (J Occup Health 1998; 40: 293–301)
منابع مشابه
Toxicokinetic Modeling of the Combined Exposure to Toluene and n-Hexane in Rats and Humans
Toxicokinetic Modeling of the Combined Exposure to Toluene and n-Hexane in Rats and Humans: Nabeel ALI, et al. Département de médecine du travail et d’hygiène du milieu, Faculté de médecine, Université de Montréal—We studied the toxicokinetic fate of toluene (TOL) and n-hexane (HEX) in rats exposed to mixtures of these solvents by inhalation during 4 hours. We developed and validated a physiolo...
متن کاملEvaluation of Pharmacokinetic Drug Interactions in Prescriptions of Intensive Care Unit (ICU) in a Teaching Hospital
Concomitant use of several drugs by ICU( Intensive Care Unit) patients is often unavoidable. In these patients, pharmacokinetic drug interactions are very likely. The current study was designed to evaluate these interactions in patients hospitalized in an ICU of a teaching hospital in Tehran, Iran. A questionnaire was designed and used to collect study data. The study was done in the ICU of a t...
متن کاملEvaluation of Pharmacokinetic Drug Interactions in Prescriptions of Intensive Care Unit (ICU) in a Teaching Hospital
Concomitant use of several drugs by ICU( Intensive Care Unit) patients is often unavoidable. In these patients, pharmacokinetic drug interactions are very likely. The current study was designed to evaluate these interactions in patients hospitalized in an ICU of a teaching hospital in Tehran, Iran. A questionnaire was designed and used to collect study data. The study was done in the ICU of a t...
متن کاملPhysiologically based pharmacokinetic modeling in risk assessment Development of Bayesian population methods
This thesis is based on the publications listed below, referred to in the text by their Roman numerals. The papers are reprinted with the kind permission of the publishers of the journals. Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromet...
متن کاملHuman inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine.
Urinary biomarkers of exposure are used widely in biomonitoring studies. The commonly used urinary biomarkers for the aromatic solvents toluene (T), ethylbenzene (E), and m-xylene (X) are o-cresol, mandelic acid, and m-methylhippuric acid. The toxicokinetics of these biomarkers following inhalation exposure have yet to be described by physiologically based pharmacokinetic (PBPK) modeling. Five ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2001